Xenotransplantation Market Size - By Product Type (Organ Preservation Solution, Transplant Diagnostics, Xeno Products), By Application (Kidney, Heart, Liver, Lung), By End-use– Global Forecast to 2035
Published Date: January - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationXenotransplantation Market Size - By Product Type (Organ Preservation Solution, Transplant Diagnostics, Xeno Products), By Application (Kidney, Heart, Liver, Lung), By End-use– Global Forecast to 2035
Xenotransplantation Market Size
Xenotransplantation Market size was valued at USD 15.34 billion in 2024 and is estimated to account for USD 34.45 billion by 2035. Xenotransplantation refers to the transplantation of living cells, tissues, or organs from one species to another, with the transplantation of animal (xenogeneic) organs or tissues into humans. It involves the transfer of biological material across species boundaries to replace or repair damaged or dysfunctional organs in recipients. The objective of xenotransplantation is to address the shortage of human organs available for transplantation by utilizing organs or tissues from non-human animal sources.
To get key market trends
The rising demand for organ transplantation and the potential of xenotransplantation as a solution will create ample evolution opportunities to the business. For instance, as per the Global Observatory On Donation And Transplantation, more than 154,302 organ transplant procedures were performed in the year 2021. Among which kidney transplants registered highest share with 95,532 procedures worldwide. Moreover, high demand for organ transplants coupled with shortage of organ donors leads to long waiting times and high mortality rates.
| Report Attribute | Details |
|---|---|
| Base Year | 2024 |
| Xenotransplantation Market Size in 2024 | USD 15.34 Billion |
| Forecast Period | 2024 to 2035 |
| Forecast Period 2023 to 2032 CAGR | 11.45% |
| 2035 Value Projection | USD 34.45 Billion |
| Historical Data for | 2019 to 2024 |
| No. of Pages | 345 |
| Tables, Charts & Figures | 233 |
| Segments covered | Product Type, Application, End-use and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
What are the growth opportunities in this market?
The COVID-19 outbreak negatively impacted the xenotransplantation market. The COVID-19 pandemic had disrupted research activities in many fields, including xenotransplantation. Laboratories and research institutions faced several challenges such as temporary closures, restricted access, reduced funding, and diversion of resources toward COVID-19 research. These disruptions affected the pace of xenotransplantation research and development. The pandemic put immense pressure on healthcare systems worldwide, that led to a shift in priorities toward managing COVID-19 cases and related complications. This shift impacted the allocation of resources and attention to other healthcare areas, including xenotransplantation.
Xenotransplantation Market Trends
Advancements in organ preservation technologies, including machine perfusion and cryopreservation methods, enhance the viability and quality of xenogeneic organs.Similarly, advances in genetic engineering techniques, such as CRISPR-Cas9 allows healthcare professionals to modify animal genomes to create genetically engineered pigs or other animals with organs that are more compatible with human recipients. Further, increasing adoption of robotics in minimally invasive surgical techniques will provide potential to improve the precision and safety of xenotransplantation procedures. Robotic-assisted surgery can enhance surgical outcomes and reduce post-operative complications.
Xenotransplantation Market Analysis
Learn more about the key segments shaping this market
The xenotransplantation market by product type is segregated into organ preservation solution, transplant diagnostics, xeno product and others. The xeno product segment is further classified into organ, cell, and tissue. The transplant diagnostics segment garnered more than USD 5.45 billion revenue size in the year 2024. Growing chronic diseases burden worldwide leads to surge in the number of organ failure cases. Further, ongoing advancements in diagnostic technologies such as human leukocyte antigen (HLA) typing, non-human leukocyte antigen (nHLA) typing and donor-derived cell-free DNA (dd-cfDNA) testing among others to improve the accuracy, sensitivity, and specificity of detection, facilitating early diagnosis and intervention in the xenotransplantation. Moreover, growing usage of point-of-care testing (POCT) that offers numerous advantages of rapid results, portability, and ease of use and enable real-time monitoring of graft function, rejection, or infectious complications in xenotransplantation.
Learn more about the key segments shaping this market
On the basis of application, the xenotransplantation market is classified into kidney, heart, lungs, liver, and others. The kidney segment accounted for over 36% market share in the year 2022. The shortage of human kidneys for transplantation is a major factor driving industry development. The demand for kidney transplantation far exceeds the available supply, leading to long waiting lists and high mortality rates as xenotransplantation offers the possibility of utilizing pig kidneys or other non-human sources to overcome the shortage and provide more options for patients in need of kidney transplantation.
Based on end-use, the xenotransplantation market is subdivided into transplant centers, hospitals and others. The transplant centers segment is predicted to witness considerable growth at 13.39% CAGR by 2024. High availability of expertise with experience in organ transplantation, including xenotransplantation coupled with increasing transplant procedures among settings is anticipated to positively influence the industry gains. Additionally, transplant centers with track record of successful patient outcomes, comprehensive multidisciplinary teams, and specialized infrastructure for transplantation procedures. Growing integration of advanced technologies such as utilization of telemedicine, remote monitoring, and digital health platforms to enhance communication, remote patient management, and real-time data analysis in the context of xenotransplantation.
Looking for region specific data?
U.S. xenotransplantation market accounted for USD 8.34 billion revenue size in 2024. Growing prevalence of chronic diseases such as end-stage renal disease, heart failure, and liver failure in the U.S. is predicted to positively influence the industry expansion. Additionally, shortage of organs for transplantation is another factor increasing demand for xenotransplantation. Further, high investment in research and development activities, government initiatives and favourable regulatory policies will boost novel innovations and advancements in the xenotransplantation.
Xenotransplantation Market Share
Some of the major market participants operating in the xenotransplantation market include
- Novartis AG
- Immerge BioTherapeutics, Inc.
- United Therapeutics Corporation
- Infigen, Inc.
- eGenesis, Inc.
- NZeno Limited
- Preservation Solutions, Inc.
- Xeno Transplants Corporation
- F. Hoffmann-La Roche Ltd.
- OrganOX Limited
Xenotransplantation Industry News
- In April 2023, eGenesis collaborated with Karius, the leading infectious disease diagnostics provider. This collaboration aimed to develop infectious disease diagnostics for xenotransplantation. Such initiatives strengthen development capabilities of both companies in the significant market.
- In January 2023, United Therapeutics Corporation (UT) a public benefit corporation introduced world’s first recipient of an investigational genetically modified xenotransplant organ, UT’s UHeart. This has been designed to provide organs to patients unable to receive human organ donations, offering a competitive edge to the firm.
Xenotransplantation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2020 to 2035 for the following segments
By Product Type (USD Million)
- Organ preservation solution
- Transplant diagnostics
- Xeno products
- Organ
- Cell
- Tissue
- Others
By Application (USD Million)
- Kidney
- Heart
- Liver
- Lung
- Others
By End-use (USD Million)
- Transplant centers
- Hospitals
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey
Xenotransplantation Market Key Developments • In September 2023, United Therapeutics announced significant progress in its heart and kidney xenotransplantation programs. The company completed its second transplant of a UHeart xenoheart into a living patient and conducted a 61-day study involving the UThymoKidney xenokidney and thymus in a human pre-clinical model.
• In April 2024, United Therapeutics announced the world's first successful transplant of a UThymoKidney into a living person. This groundbreaking procedure, which included a heart pump implant, marks several important milestones in transplantation. It was the first xenothymokidney transplant in a living human, the first combined heart pump and organ transplant, and the first xenotransplant using only FDA-approved immunosuppressive drugs. •
In April 2023, eGenesis partnered with Karius to speed up xenotransplantation for patients needing organ transplants. Karius, a leader in infectious disease diagnostics, works with eGenesis, which focuses on developing human-compatible organs. Together, they enhance Karius's microbial cell-free DNA sequencing platform to detect pig pathogens. This collaboration aims to create diagnostic tools for detecting infections that could arise from pig organ donors, both before and after transplantation.
Xenotransplantation Market, Key Players
North America 1. United Therapeutics Corporation (United States) 2. eGenesis, Inc. (United States) 3. University of Maryland, Baltimore (UMB) (United States) 4. New York University Langone Health (NYU) (United States) 5. University of Alabama at Birmingham (UAB) (United States) 6. Preservation Solutions, Inc. (United States) 7. Organ Recovery Systems (United States) 8. Massachusetts General Hospital (United States) 9. Transplant Biomedical (Spain) Europe 1. F. Hoffmann-La Roche Ltd. (Switzerland) 2. OrganOX Limited (United Kingdom) 3. Transplant Biomedical (Spain) 4. Xenotransplantation Research Center (Sweden) Asia Pacific 1. Terumo Medical Corporation (Japan) 2. TransMedic, Pte. Ltd. (Singapore) 3. Bio-Med Pvt. Ltd. (India) 4. Organ Recovery Systems (operations in Asia Pacific) 5. Astellas Pharma, Inc- Japan
Frequently Asked Questions 1. What are the main applications of xenotransplantation? Answer The main applications of xenotransplantation are in the treatment of organ failure, specifically in areas such as kidney disease, heart disease, and lung disease.
2. What is the expected market size and growth rate of the xenotransplantation market? Answer The xenotransplantation market was valued at approximately USD 13.8 billion in 2023 and is expected to reach USD 25.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.94%
.3. What is driving the growth of the xenotransplantation market? Answer The primary driver of the xenotransplantation market is the global shortage of human donor organs. The increasing prevalence of chronic diseases, such as kidney disease, is further fueling market growth.
4. Which regions dominate the xenotransplantation market? Answer North America, particularly the United States, currently dominates the xenotransplantation market due to a significant shortage of donor organs, substantial investments in medical research, and a supportive regulatory environment for innovative medical technologies.
Table of Content
1. Xenotransplantation Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary
2. Global Xenotransplantation Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Product Segment 2.4.3. End-User Segment 2.4.4. Revenue (2023) 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Consolidation of the Market 2.6.1. Strategic Initiatives and Developments 2.6.2. Mergers and Acquisitions 2.6.3. Collaborations and Partnerships 2.6.4. Product Launches and Innovations
3. Xenotransplantation Market: Dynamics 3.1. Xenotransplantation Market Trends 3.2. Xenotransplantation Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Bargaining power of suppliers 3.3.2. Bargaining power of buyers 3.3.3. Threat of new entrants 3.3.4. Threat of substitutes 3.3.5. Intensity of competitive rivalry 3.4. PESTLE Analysis 3.5. Key Opinion Leader Analysis for Xenotransplantation 3.6. Analysis of Government Schemes and Initiatives Xenotransplantation Industry
4. Xenotransplantation Market: Global Market Size and Forecast by Segmentation (in USD Bn) (2023-2030) 4.1. Xenotransplantation Market Size and Forecast, by Type (2023-2030) 4.1.1. Organ Preservation Solutions 4.1.2. Transplant Diagnostics 4.1.3. Tissue Products 4.2. Xenotransplantation Market Size and Forecast, by Application (2023-2030) 4.2.1. Heart 4.2.2. Kidney 4.2.3. Lung 4.2.4. Other Organs 4.3. Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 4.3.1. Hospitals 4.3.2. Transplantation centers 4.3.3. Others
5. North America Xenotransplantation Market Size and Forecast by Segmentation (in USD Bn) (2023-2030) 5.1. North America Xenotransplantation Market Size and Forecast, by Type (2023-2030) 5.1.1. Organ Preservation Solutions 5.1.2. Transplant Diagnostics 5.1.3. Tissue Products 5.2. North America Xenotransplantation Market Size and Forecast, by Application (2023-2030) 5.2.1. Heart 5.2.2. Kidney 5.2.3. Lung 5.2.4. Other Organs 5.3. North America Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 5.3.1. Hospitals 5.3.2. Transplantation centers 5.3.3. Others 5.4. North America Xenotransplantation Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Xenotransplantation Market Size and Forecast, by Type (2023-2030) 5.4.1.1.1. Organ Preservation Solutions 5.4.1.1.2. Transplant Diagnostics 5.4.1.1.3. Tissue Products 5.4.1.2. United States Xenotransplantation Market Size and Forecast, by Application (2023-2030) 5.4.1.2.1. Heart 5.4.1.2.2. Kidney 5.4.1.2.3. Lung 5.4.1.2.4. Other Organs 5.4.1.3. United States Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 5.4.1.3.1. Hospitals 5.4.1.3.2. Transplantation centers 5.4.1.3.3. Others 5.4.2. Canada 5.4.2.1. Canada Xenotransplantation Market Size and Forecast, by Type (2023-2030) 5.4.2.1.1. Organ Preservation Solutions 5.4.2.1.2. Transplant Diagnostics 5.4.2.1.3. Tissue Products 5.4.2.2. Canada Xenotransplantation Market Size and Forecast, by Application (2023-2030) 5.4.2.2.1. Heart 5.4.2.2.2. Kidney 5.4.2.2.3. Lung 5.4.2.2.4. Other Organs 5.4.2.3. Canada Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 5.4.2.3.1. Hospitals 5.4.2.3.2. Transplantation centers 5.4.2.3.3. Others 5.4.3. Mexico 5.4.3.1. Mexico Xenotransplantation Market Size and Forecast, by Type (2023-2030) 5.4.3.1.1. Organ Preservation Solutions 5.4.3.1.2. Transplant Diagnostics 5.4.3.1.3. Tissue Products 5.4.3.2. Mexico Xenotransplantation Market Size and Forecast, by Application (2023-2030) 5.4.3.2.1. Heart 5.4.3.2.2. Kidney 5.4.3.2.3. Lung 5.4.3.2.4. Other Organs 5.4.3.3. Mexico Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 5.4.3.3.1. Hospitals 5.4.3.3.2. Transplantation centers 5.4.3.3.3. Others
6. Europe Xenotransplantation Market Size and Forecast by Segmentation (in USD Bn) (2023-2030) 6.1. Europe Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.2. Europe Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.3. Europe Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4. Europe Xenotransplantation Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.1.2. United Kingdom Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.1.3. United Kingdom Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4.2. France 6.4.2.1. France Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.2.2. France Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.2.3. France Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.3.2. Germany Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.3.3. Germany Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.4.2. Italy Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.4.3. Italy Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.5.2. Spain Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.5.3. Spain Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.6.2. Sweden Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.6.3. Sweden Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.7.2. Austria Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.7.3. Austria Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Xenotransplantation Market Size and Forecast, by Type (2023-2030) 6.4.8.2. Rest of Europe Xenotransplantation Market Size and Forecast, by Application (2023-2030) 6.4.8.3. Rest of Europe Xenotransplantation Market Size and Forecast, by End Use (2023-2030)
7. Asia Pacific Xenotransplantation Market Size and Forecast by Segmentation (in USD Bn) (2023-2030) 7.1. Asia Pacific Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.2. Asia Pacific Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.3. Asia Pacific Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4. Asia Pacific Xenotransplantation Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.1.2. China Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.1.3. China Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.2.2. S Korea Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.2.3. S Korea Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.3.2. Japan Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.3.3. Japan Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.4. India 7.4.4.1. India Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.4.2. India Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.4.3. India Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.5.2. Australia Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.5.3. Australia Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.6.2. Indonesia Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.6.3. Indonesia Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.7.2. Malaysia Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.7.3. Malaysia Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.8.2. Vietnam Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.8.3. Vietnam Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.9.2. Taiwan Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.9.3. Taiwan Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Xenotransplantation Market Size and Forecast, by Type (2023-2030) 7.4.10.2. Rest of Asia Pacific Xenotransplantation Market Size and Forecast, by Application (2023-2030) 7.4.10.3. Rest of Asia Pacific Xenotransplantation Market Size and Forecast, by End Use (2023-2030)
8. South America Xenotransplantation Market Size and Forecast by Segmentation (in USD Bn) (2023-2030) 8.1. South America Xenotransplantation Market Size and Forecast, by Type (2023-2030) 8.2. South America Xenotransplantation Market Size and Forecast, by Application (2023-2030) 8.3. South America Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 8.4. South America Xenotransplantation Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Xenotransplantation Market Size and Forecast, by Type (2023-2030) 8.4.1.2. Brazil Xenotransplantation Market Size and Forecast, by Application (2023-2030) 8.4.1.3. Brazil Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Xenotransplantation Market Size and Forecast, by Type (2023-2030) 8.4.2.2. Argentina Xenotransplantation Market Size and Forecast, by Application (2023-2030) 8.4.2.3. Argentina Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest of South America Xenotransplantation Market Size and Forecast, by Type (2023-2030) 8.4.3.2. Rest of South America Xenotransplantation Market Size and Forecast, by Application (2023-2030) 8.4.3.3. Rest of South America Xenotransplantation Market Size and Forecast, by End Use (2023-2030)
9. Middle East and Africa Xenotransplantation Market Size and Forecast by Segmentation (in USD Bn) (2023-2030) 9.1. Middle East and Africa Xenotransplantation Market Size and Forecast, by Type (2023-2030) 9.2. Middle East and Africa Xenotransplantation Market Size and Forecast, by Application (2023-2030) 9.3. Middle East and Africa Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 9.4. Middle East and Africa Xenotransplantation Market Size and Forecast, by Country (2023-2030) 9.4.1. South Africa 9.4.1.1. South Africa Xenotransplantation Market Size and Forecast, by Type (2023-2030) 9.4.1.2. South Africa Xenotransplantation Market Size and Forecast, by Application (2023-2030) 9.4.1.3. South Africa Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 9.4.2. GCC 9.4.2.1. GCC Xenotransplantation Market Size and Forecast, by Type (2023-2030) 9.4.2.2. GCC Xenotransplantation Market Size and Forecast, by Application (2023-2030) 9.4.2.3. GCC Xenotransplantation Market Size and Forecast, by End Use (2023-2030) 9.4.3. Rest Of MEA 9.4.3.1. Rest Of MEA Xenotransplantation Market Size and Forecast, by Type (2023-2030) 9.4.3.2. Rest Of MEA Xenotransplantation Market Size and Forecast, by Application (2023-2030) 9.4.3.3. Rest Of MEA Xenotransplantation Market Size and Forecast, by End Use (2023-2030)
10. Company Profile: Key Players 10.1. United Therapeutics Corporation (United States) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis (Technological strengths and weaknesses) 10.1.5. Strategic Analysis (Recent strategic moves) 10.1.6. Recent Developments 10.2. eGenesis, Inc. (United States) 10.3. University of Maryland, Baltimore (UMB) (United States) 10.4. New York University Langone Health (NYU) (United States) 10.5. University of Alabama at Birmingham (UAB) (United States) 10.6. Preservation Solutions, Inc. (United States) 10.7. Organ Recovery Systems (United States) 10.8. Massachusetts General Hospital (United States) 10.9. Transplant Biomedical (Spain) 10.10. F. Hoffmann-La Roche Ltd. (Switzerland) 10.11. OrganOX Limited (United Kingdom) 10.12. Transplant Biomedical (Spain) 10.13. Xenotransplantation Research Center (Sweden) 10.14. Terumo Medical Corporation (Japan) 10.15. TransMedic, Pte. Ltd. (Singapore) 10.16. Bio-Med Pvt. Ltd. (India) 10.17. Organ Recovery Systems (operations in Asia Pacific) 10.18. Astellas Pharma, Inc- Japan
11. Key Findings and Analyst Recommendations
12. Xenotransplantation Market: Research Methodology 13. Market Size Estimation Methodology 13.1. Bottom-Up Approach 13.2. Top-Down Approach
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy